Answers are grounded in this paper and cite their sources.
Forty-two experienced clinicians who work with consumers diagnosed with schizophrenia were surveyed in order to assess the feasibility of using mobile applications as an adjunct to conventional treatment. Clinicians reported that over two-thirds of their consumers could safely make use of this technology. In addition, a majority of consumers were seen as likely to benefit from all but one of the fifteen functions performed by the investigational app (TherAPPist).
No takes yet. Share an insight, caveat, or question.
Chambliss et al. (2014) studied this question.
Synapse has enriched 4 related papers. Consider them for comparative context: